Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 20, 2026

30 minutes ago

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

GlobeNewswire

30 minutes ago

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

GlobeNewswire

30 minutes ago

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

GlobeNewswire

30 minutes ago

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

GlobeNewswire

30 minutes ago

COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations

GlobeNewswire

30 minutes ago

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

GlobeNewswire

30 minutes ago

Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies

GlobeNewswire

30 minutes ago

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

GlobeNewswire

30 minutes ago

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

GlobeNewswire

30 minutes ago

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

GlobeNewswire

30 minutes ago

BVI gibt bekannt, dass Virtuoso®, eine neue chirurgische Plattform mit Doppelfunktion, die CE-Kennzeichnung gemäß EU-MDR erhalten hat

GlobeNewswire

30 minutes ago

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

GlobeNewswire

30 minutes ago

BVI annonce l’obtention du marquage CE au titre du Règlement européen sur les dispositifs médicaux pour Virtuoso®, une toute nouvelle plateforme chirurgicale à double fonction

GlobeNewswire

30 minutes ago

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

GlobeNewswire

30 minutes ago

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

GlobeNewswire

30 minutes ago

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

GlobeNewswire

30 minutes ago

Standard Dental Labs Inc. Appoints Brendan Cummins to Board of Directors

GlobeNewswire

30 minutes ago

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

GlobeNewswire

30 minutes ago

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

GlobeNewswire

30 minutes ago

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

GlobeNewswire